Comment on ‘Risk of inflammatory dermatoses following COVID-19 infection: a cohort study of 204,241 patients’: considerations regarding causal inference

Clicks: 33
ID: 316912
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #80 of 252 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 252 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Our correspondence discusses an important interpretive consideration regarding the distinction between persistent response among selected responders and durable disease control in the broader treated population in a recent study of long-term lebrikizumab efficacy in atopic dermatitis. We highlight how responder-enriched analyses, attrition, and treatment persistence may influence interpretation of long-term stability outcomes and encourage cautious interpretation of durability claims in chronic inflammatory skin disease.
Reference Key
openalex_W7164169521 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag245
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.